Nitric oxide-targeted therapy inhibits stemness and increases the efficacy of tamoxifen in estrogen receptor-positive breast cancer cells

SILVIA GUIL LUNAJUAN RAFAEL DE LA HABA RODRIGUEZ2026-01-292026-01-29202110.1038/s41374-020-00507-z2-s2.0-85096970564https://www.scopus.com/inward/record.uri?eid=2-s2.https://ucocris.uco.es/handle/123456789/32677Cell BiologyMolecular BiologyPathology and Forensic MedicineNitric oxide-targeted therapy inhibits stemness and increases the efficacy of tamoxifen in estrogen receptor-positive breast cancer cellsresearch article